Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5381-5388

  Yan, Hui Wen ^a   Hu, Wei Xin ^a   Zhang, Jie Ying ^a   Wang, Ye ^a   Xia, Kun ^a   Peng, Min Yuan ^a   Liu, Jing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Erythroid differentiation; K562 cells; Resveratrol

Indexed keywords

CASPASE 3; GAPDH PROTEIN; GLYCOPHORIN A; HBA1 PROTEIN; HBB PROTEIN; HEMOGLOBIN GAMMA CHAIN; PROTEIN; RESVERATROL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG EFFECT; ERYTHROID DIFFERENTIATION; HUMAN; HUMAN CELL; K562 CELL LINE; LEUKEMIA CELL LINE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY;

ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL DIFFERENTIATION; CELL PROLIFERATION; ERYTHROID CELLS; GLYCOPHORIN; HUMANS; K562 CELLS; RECEPTORS, TRANSFERRIN; STILBENES;

EID: 84904716845     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1701-y     Document Type: Article

References (40)

1. Clarkson B, Strife A. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia. 1993;7:1683-721. (Pubitemid 23347286)
2. Lazzio CB, Lazzio BB. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood. 1975;45:321-34.
3. Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A, et al. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer. 1976;18:421-31.
4. Melo JV. Themolecular biology of chronicmyeloid leukaemia. Leuk Off J Leuk Soc Am Leuk Res Fund UK. 1996;10:751-6.
5. Advani AS, Pendergast AM. Bcr-Abl variants: biological and clinical aspects. Leuk Res. 2002;26:713-20. (Pubitemid 34628369)
6. Bruecher-Encke B, Griffin JD, Neel BG, Lorenz U. Role of the tyrosine phosphtase SHP-1 in K562 cell differentiation. Leukemia. 2001;15:1424-32. (Pubitemid 32785312)
7. Tabilio A, Pelicci P, Vinci G, Mannoni P, Civin CI, Vainchenker W, et al. Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res. 1983;43:4569-74. (Pubitemid 13014183)
8. Meshkini A, Yazdanparast R. Induction of megakaryocytic differentiation in chronic myelogenous leukemia cell K562 by 3-hydrogenk wadaphnin. Biochem Mol Biol. 2007;40:944-51. (Pubitemid 350242280)
9. Alitalo R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk Res. 1990;14:501-14. (Pubitemid 20213713)
10. Sutherland JA, Turner AR, Mannoni P, McGann LE, Turc JM. Differentiation of K562 leukemia cell along eryhroid, macrophage, and megakaryocyte lineage. J Biol Respir Mod. 1986;5:25-62.
11. Huang HL, Chen YC, Huang YC, Yang KC, Pan H, Shih SP, et al. Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells. PLoS One. 2011;6:e29014.
12. D'Introno A, Paradiso A, Scoditti E, D'Amico L, De Paolis A, Carluccio MA, et al. Antioxidant and anti-inflammatory properties of tomato fruits synthesizing different amounts of stilbenes. Plant Biotechnol J. 2009;7:422-9.
13. Schubert R, Fischer R, Hain R, Schreier PH, Bahnweg G, Ernst D, et al. An ozoneresponsive region of the grapevine resveratrol synthase promoter differs from the basal pathogen-responsive sequence. Plant Mol Biol. 1997;34(3):417-26. (Pubitemid 27284876)
14. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem. 1997;30:91-113. (Pubitemid 27180922)
15. Hsieh TC, Wang Z, Hamby CV, Wu JM. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem Biophys Res Commun. 2005;334:223-30. (Pubitemid 40978529)
16. Wu CP, Calcagno AM, Hladky SB, Ambudkar SV, Barrand MA. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J. 2005;272:4725-40. (Pubitemid 41366995)
17. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem. 2000;78:429-41. (Pubitemid 30491071)
18. Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 2000;25:639-45. (Pubitemid 30156589)
19. Mitchell SH, Zhu W, Young CY. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 1999;59:5892-5. (Pubitemid 30004946)
20. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. The anti- proliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol. 2012;13:1375-86.
21. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Raul F. Antiproliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 2000;158:85-91. (Pubitemid 30627485)
22. Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol. 2003;9:408-11. (Pubitemid 36372096)
23. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med. 2005;16:533-40.
24. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanismof cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med. 2001;8:3-17.
25. Rossi D, Guerrini A, Bruni R, Brognara E, Borgatti M, Gambari R, et al. Trans-resveratrol in nutraceuticals: issues in retail quality and effectiveness. Molecules. 2012;17:12393-405.
26. Luzi C, Brisdelli F, Cinque B, Cifone G, Bozzi A. Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Biochem Pharmacol. 2004;68:2019-30. (Pubitemid 39346192)
27. Chakraborty PK, Mustafi SB, Ganguly S, Chatterjee M, Raha S. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. Cancer Sci. 2008;99:1109-16. (Pubitemid 351676621)
28. Puissant A, Grosso S, Jacquel A, Belhacene N, Colosetti P, Cassuto JP, et al. Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol. FASEB J. 2008;22:1894-904. (Pubitemid 351811466)
29. Santos Franco S, De Falco L, Ghaffari S, Brugnara C, Sinclair DA, Mattè A, Iolascon A, Mohandas N, Bertoldi M, An X, Siciliano A, Rimmelé P, Cappellini MD, Michan S, Zoratti E, Janin A, De Franceschi L. Resveratrol accelerates erythroid maturation by activation of FOXO3 and ameliorates anemia in beta-thalassemic mice. Haematologica 2014; (in press)
30. Fibach E, Prus E, Bianchi N, Zuccato C, Breveglieri G, Salvatori F, et al. Resveratrol: antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. Int J Mol Med. 2012;29:974-82.
31. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A. 2009;106:17413-8.
32. Liu J, Narla M, An X. Membrane assembly during erythropoiesis. Curr Opin Hematol. 2011;18:133-8.
33. Hu J, Liu J, Xue F, Halverson G, Reid M, Guo A, et al. Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. Blood. 2013;121(16):3246-53.
34. -) mice due to decreased survival of early erythroblasts. Blood. 2001;98(12):3261-73.
35. Asou H, Koshizuka K, Kyo T, Takata N, Kamada N, Koeffier HP. Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias. Int J Hematol. 2002;75:528-33.
36. Cao Y, Wang F, Liu HY, Fu ZD, Han R. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells. J Asian Nat Prod Res. 2005;7:633-41. (Pubitemid 40909332)
37. Rodrigue CM, Arous N, Bachir D, Smith-Ravin J, Romeo PH, Galacteros F, et al. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol. 2001;113:500-7. (Pubitemid 32523162)
38. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137:1062-75.
39. Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, et al. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res. 2010;70:1042-52.
40. Griffiths RE, Kupzig S, Cogan N, Mankelow TJ, Betin VM, Trakarnsanga K, et al. The ins and outs of human reticulocyte maturation: autophagy and the endosome/exosome pathway. Autophagy. 2012;8:1150-1.